* For quality assurance purposes. Not a Maine compliance certificate.
Shoki Masque Hash Rosin (Concentrate)
Produced: Apr 15, 2022
Client: Art and Craft LLC // Batch Result: Pass
Batch No.: SH.21.HR
Matrix: Concentrate
Sample ID: NAL-220413-002
Collected On: Apr 13, 2022
Received On: Apr 13, 2022
Sample Size: 0.7 g
Sampled By: Geoffrey Nosach
Received By: Alex Eramo
Cultivator
Geoffrey Nosach
License
CGR#26091
Type
Medicinal - Caregiver
Results Certified By:
Barry Chaffin
COO, Nova Analytic Labs
Apr 15, 2022
Results Certified By:
Greg Newland
CSO, Nova Analytic Labs
Apr 15, 2022
Results Certified By:
Chris Altomare
CEO, Nova Analytic Labs
Apr 15, 2022
Analyte | Labeled Amount | Limit | Detected | Pass/Fail |
---|---|---|---|---|
CBC | ND | N/A | ||
CBCA | < LOQ | N/A | ||
CBD | ND | N/A | ||
CBDA | ND | N/A | ||
CBDV | ND | N/A | ||
CBDVA | ND | N/A | ||
CBG | ND | N/A | ||
CBGA | 9.56 % | N/A | ||
CBL | ND | N/A | ||
CBLA | ND | N/A | ||
CBN | ND | N/A | ||
CBNA | ND | N/A | ||
Δ8-THC | ND | N/A | ||
Δ9-THC | 1.31 % | N/A | ||
Δ10-THC | ND | N/A | ||
Exo-THC | ND | N/A | ||
THCA | 67.3 % | N/A | ||
THCV | ND | N/A | ||
THCVA | 2.90 % | N/A | ||
Total THC (Total THC = (THCA x 0.877) + Delta-9-THC)
|
60.3 % | N/A | ||
Total CBD (Total CBD = (CBDA x 0.877) + CBD)
|
ND | N/A |
Analyte | Labeled Amount | Detected | Pass/Fail |
---|---|---|---|
Total Terpenes | 6.56 % | N/A | |
β-Caryophyllene | 2.65 % | N/A | |
d-Limonene | 1.43 % | N/A | |
α-Humulene | 1.15 % | N/A | |
Linalool | 0.685 % | N/A | |
β-Pinene | 0.214 % | N/A | |
α-Pinene | 0.123 % | N/A | |
trans-Nerolidol | 0.0926 % | N/A | |
β-Myrcene | 0.0888 % | N/A | |
Caryophyllene Oxide | 0.0615 % | N/A | |
Terpinolene | 0.0348 % | N/A | |
Camphene | 0.0346 % | N/A | |
α-Bisabolol | < LOQ | N/A | |
β-Ocimene | < LOQ | N/A | |
α-Ocimene | ND | N/A | |
α-Terpinene | ND | N/A | |
cis-Nerolidol | ND | N/A | |
Δ3-Carene | ND | N/A | |
Eucalyptol | ND | N/A | |
γ-Terpinene | ND | N/A | |
Geraniol | ND | N/A | |
Isopulegol | ND | N/A | |
p-Cymene | ND | N/A |
* For quality assurance purposes. Not a Maine compliance certificate.
ALL TESTS WERE PERFORMED IN ACCORDANCE WITH THE RULES AND REGULATIONS SET FORTH IN THE MAINE ADULT USE PROGRAM. LABORATORY SAMPLING PROTOCOLS ARE GOVERNED BY THE OCP'S SAMPLING GUIDANCE DOCUMENTS. ALL INFORMATION PROVIDED BY THE CLIENT, INCLUDING SELF SAMPLING, MUST BE ACCURATE AND ADHERE TO THE SAME RULES AND REGULATIONS. HOWEVER, CLIENT PROVIDED INFORMATION, INCLUDING SAMPLING, IS ULTIMATELY THE RESPONSIBILITY OF THE PROVIDING LICENSEE, REGISTERED CAREGIVER, PATIENT OR THE LIKE AND FAILURE TO FOLLOW SAID PROTOCOLS COULD LEAD TO ERRONEOUS TEST RESULTS. NOTE: NOT ALL POTENTIAL AND/OR EXISTING HAZARDS WERE ANALYZED. THIS CERTIFICATE OF ANALYSIS IS RELEVANT ONLY TO THOSE ITEMS TESTED. THE SAMPLE WAS PROVIDED TO THE LABORATORY FOR TESTING BY THE CLIENT AND THE SAMPLE WAS TESTED AS RECEIVED.